AnterogenCoLtd Financials
| 065660 Stock | KRW 19,790 90.00 0.45% |
AnterogenCoLtd |
Understanding current and past AnterogenCoLtd Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AnterogenCoLtd's financial statements are interrelated, with each one affecting the others. For example, an increase in AnterogenCoLtd's assets may result in an increase in income on the income statement.
Please note, the presentation of AnterogenCoLtd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AnterogenCoLtd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AnterogenCoLtd's management manipulating its earnings.
AnterogenCoLtd Stock Summary
AnterogenCoLtd competes with DOLLAR TREE. ,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7065660003 |
| Business Address | Namsung Plaza, Seoul, |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Benchmark | Dow Jones Industrial |
| Website | anterogen.com |
| Phone | 82 2 2104 0391 |
| Currency | KRW - South Korean Won |
You should never invest in AnterogenCoLtd without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AnterogenCoLtd Stock, because this is throwing your money away. Analyzing the key information contained in AnterogenCoLtd's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AnterogenCoLtd Key Financial Ratios
AnterogenCoLtd's financial ratios allow both analysts and investors to convert raw data from AnterogenCoLtd's financial statements into concise, actionable information that can be used to evaluate the performance of AnterogenCoLtd over time and compare it to other companies across industries.| Return On Equity | -5.92 | |||
| Return On Asset | -0.0231 | |||
| Beta | 0.37 |
AnterogenCoLtd Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AnterogenCoLtd's current stock value. Our valuation model uses many indicators to compare AnterogenCoLtd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AnterogenCoLtd competition to find correlations between indicators driving AnterogenCoLtd's intrinsic value. More Info.AnterogenCoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AnterogenCoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AnterogenCoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AnterogenCoLtd Systematic Risk
AnterogenCoLtd's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AnterogenCoLtd volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on AnterogenCoLtd correlated with the market. If Beta is less than 0 AnterogenCoLtd generally moves in the opposite direction as compared to the market. If AnterogenCoLtd Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AnterogenCoLtd is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AnterogenCoLtd is generally in the same direction as the market. If Beta > 1 AnterogenCoLtd moves generally in the same direction as, but more than the movement of the benchmark.
AnterogenCoLtd March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AnterogenCoLtd help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AnterogenCoLtd. We use our internally-developed statistical techniques to arrive at the intrinsic value of AnterogenCoLtd based on widely used predictive technical indicators. In general, we focus on analyzing AnterogenCoLtd Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AnterogenCoLtd's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.05 | |||
| Information Ratio | 0.122 | |||
| Maximum Drawdown | 37.9 | |||
| Value At Risk | (4.38) | |||
| Potential Upside | 7.75 |
Complementary Tools for AnterogenCoLtd Stock analysis
When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |